This research aims at the preclinical validation of the novel proposed Nuclear Transfer (NT) technology to overcome female-related infertility, to avoid oocyte donation. The NT technology involves the transfer of the nuclear genome from a patient’s inferior quality oocyte to a healthy donor counterpart from which the nuclear genome was removed, to enable a chance on their own genetic child.